Research
Hormonal
GLP-1 receptor agonists have been successfully used in the treatment of obesity and type 2 diabetes.
GLP-1 receptor agonists can be considered as a treatment option for patients with obesity and T2DM.
StrongSupportsmedium confidence
GLP-1 receptor agonists have been successfully used.
Why this rating
The abstract discusses the successful application of GLP-1 receptor agonists.
Source
New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists
Ferenc Sztanek et al. · Biomedicines · 2024
reviewCited 35×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →